Embr Labs, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Embr Labs, Inc. - overview
Established
2014
Location
Somerville, MA, US
Primary Industry
Healthcare IT
About
Embr Labs, Inc. specializes in innovative temperature control technology, focusing on personalized thermal sensations to enhance user comfort. Their flagship product, the Embr Wave, addresses various temperature-related challenges for consumers. Founded in 2014 in Somerville, US, Embr Labs, Inc.
provides personalized temperature management solutions. Co-founded by Matt Smith, Matthew Smith, and Sam Shames, the company has undergone various strategic developments to refine its offerings. The firm's CEO is Elizabeth Gazda. Embr Labs raised USD 5.
97 mn in funding on September 29, 2021, marking its total fundraising at USD 5. 97 mn across four deals. Embr Labs specializes in providing innovative temperature control solutions through its flagship product, the Embr Wave. This smart wristband is designed to deliver personalized thermal sensations that help users manage their comfort levels by offering both cooling and warming effects at the touch of a button.
The product targets various use cases, including relief from hot flashes, stress reduction, improved sleep quality, and general temperature regulation, making it suitable for a wide range of consumers, particularly those experiencing menopause or stress-related discomfort. The Embr Wave has been clinically validated, demonstrating its effectiveness in enhancing overall well-being by stimulating temperature-sensitive nerves on the wrist. The company markets its products primarily in North America, Australia, and select countries across Europe, catering to both direct consumers and health-conscious individuals seeking a natural alternative for temperature management. Embr Labs generates revenue through direct-to-consumer sales of the Embr Wave wristband and related products.
The company's business model includes options for purchasing the device outright or renting it at a monthly fee. Consumers can opt for the Embrship subscription, which offers additional benefits such as discounts on accessories and exclusive offers. The flagship Embr Wave wristband is available for purchase, typically with a money-back guarantee, ensuring customer satisfaction. The pricing structure is designed to appeal to a diverse clientele, including individual consumers needing temperature relief and those interested in trying the product without a long-term commitment.
Transactions occur primarily through the company’s e-commerce platform, which facilitates a streamlined purchasing process for customers across various geographical markets. Following the latest funding round in September 2021, which raised USD 5. 97 mn, Embr Labs aims to further develop its product line with new innovations in temperature control technology. The company is targeting expansion into additional markets across North America and Europe, with specific plans to enter new geographic regions by late 2023.
This funding will be utilized to support product development, enhance marketing efforts, and scale operations to meet growing demand.
Current Investors
Social Starts, PBJ Capital, Bose Ventures
Primary Industry
Healthcare IT
Sub Industries
Medical Devices & Equipment, Software
Website
www.embrlabs.com
Verticals
Artificial Intelligence, HealthTech, Mobile Apps, Wearables & Quantified Self
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.